Know Cancer

or
forgot password

    • cancer clinical trials in houston, TX

    • Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN #0601) (The SCURT Study)
    University of Texas MD Anderson Cancer Research Center
    Houston, Texas 77030
    Sickle Cell Disease
    Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Diarrhea
    Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
    M D Anderson Cancer Center
    Houston, Texas 77030
    Ovarian Stromal Cancer
    Improving Pain and Function in Hip Fracture
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Pain, Hip Fractures
    Neoadjuvant Erlotinib (Tarceva) in Transitional Cell Carcinoma
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Transitional Cell Carcinoma
    Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
    The Methodist Hosptial
    Houston, Texas 77030
    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma
    Phase II Neoadjuvant in Inflammatory Breast Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Bladder Cancer
    Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD
    Texas Childrens Hospital
    Houston, Texas 77030
    Graft vs Host Disease, Graft-Versus-Host Disease
    Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia
    The University of Texas M.D. Anderson Cancer Center
    Houston, Texas
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Chronic Lymphocytic Leukemia, Leukemia
    Adherence to Swallowing Exercises in Oropharyngeal Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Head and Neck Cancer
    Intrapleural Catheter Daily Versus Three Times a Week Drainage
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Advanced Cancer, Pleural Effusion
    Doxil, Bevacizumab and Temsirolimus Trial
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Advanced Cancer
    Symptom Management in African-American Men With Localized Prostate Cancer
    Dan L. Duncan Cancer Center at Baylor College of Medicine
    Houston, Texas 77030
    Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
    MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Pancreatic Cancer, Pancreatic Adenocarcinoma
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    University of Texas - MD Anderson
    Houston, Texas 77030
    Melanoma
    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Malignant Mesothelioma
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    M D Anderson Cancer Center
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Lynne Cohen Consortium Project: Multi-Center Database/Registry
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Ovarian Cancer, Breast Cancer
    A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
    MD Anderson Cancer Center

    Trial Locations
    MD Anderson Cancer Center
    Texas Children's Cancer Center
    Leukemia
    Radiation Therapy and Cardiac Enzymes
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Tumor
    Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline AML and High-Risk MDS
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Acute Myeloid Leukemia, Myelodysplastic Syndrome
    Personalized Treatment Selection for Metastatic Breast Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
    Gulf Coast Regional Blood Center
    Houston, Texas 77054
    Healthy
    A Study of Nilotinib Versus Imatinib in GIST Patients
    MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (13)
    Houston, Texas 77030-4009
    Gastrointestinal Stromal Tumor (GIST)
    Childhood Cancer Survivor Survey
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Cancer
    Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
    UT MD Anderson Cancer Center

    Trial Locations
    UT MD Anderson Cancer Center
    St. Luke's Episcopal Hospital
    Texas Women's Hospital
    Hyperplasia, Endometrial Cancer
    Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
    Baylor College of Medicine Dept.of Baylor College of Med.

    Trial Locations
    Baylor College of Medicine Dept.of Baylor College of Med.
    University of Texas, Houston Medical School UT Physicians Oncology
    MD Anderson Cancer Center/University of Texas Dept of MD Anderson (18)
    Diffuse Large B-cell Lymphoma
    Pelvic Exenteration for Gynecologic Malignancy
    St. Luke's Episcopal Hospital
    Houston, Texas 77030
    Cervical Cancer, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Gynecologic Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Lung Cancer
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    M D Anderson Cancer Center
    Houston, Texas 77030
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Chronic Lymphocytic Leukemia
    Cancer Support Programs
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Prostate Cancer
    Pelvic Fractures and Radiation Therapy for Cervical Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Cervical Cancer, Endometrial Cancer, Vaginal Cancer
    Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Hematologic Diseases, Leukemia, Lymphoma, Myeloma
    Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    B-Cell Chronic Lymphocytic Leukemia
    Fludarabine, Cytarabine, Filgrastim and Idarubicin in Core Binding Factor (CBF) Leukemias
    The University of Texas M.D. Anderson Cancer Center
    Houston, Texas
    Acute Myelogenous Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    Ben Taub General Hospital
    Methodist Hospital
    M D Anderson Cancer Center
    Veterans Administration Medical Center
    Saint Luke's Episcopal Hospital
    Lyndon Baines Johnson General Hospital
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Brain Cancer, Central Nervous System Diseases
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    M. D. Anderson Cancer Center at University of Texas

    Trial Locations
    M. D. Anderson Cancer Center at University of Texas
    Methodist Hospital
    Endometrial Cancer, Fatigue, Neurotoxicity
    Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Stem Cell Transplantation, Leukemia
    A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
    MD Anderson Cancer Centre
    Houston, Texas 77030
    Smouldering Systemic Mastocytosis, Indolent Systemic Mastocytosis, Cutaneous Mastocytosis With Handicap, Mastocytosis
    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Chronic Myelogenous Leukemia
    A Study of QBI-139 in Subjects With Advanced Solid Tumors
    The University of Texas M. D. Anderson Cancer Center
    Houston, Texas 77030
    Solid Tumors
    A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Multiple Myeloma, Plasma Cell Leukemia